Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial

Overview of attention for article published in Trials, December 2014

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 114 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 39 publications that cite this research output.

39

The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.

Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature

Article in Diagnostics (December 2023)

Is the Y90-Radioembolization treatment effective on the intermediate-advanced stage of Hepatocellular Carcinoma and What is the Albumin-Bilirubin score's prediction factor for survival?

Article in Hepatology Forum (June 2023)

Combining Selective Internal Radiation Therapy with Immunotherapy in Treating Hepatocellular Carcinoma and Hepatic Colorectal Metastases: A Systematic Review

Article in Cancer Biotherapy & Radiopharmaceuticals (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.